" Telix Pharmaceuticals (ASX:TLX) commences prostate cancer clinical trial
Telix Pharmaceuticals (TLX) has been given the green light to commence a phase three clinical trial of its targeted therapy candidate TLX591 in
" Bod Australia (ASX:BDA) records highest ever month of MediCabilis sales
Bod Australia (BDA) has recorded its highest-ever month of medicinal cannabis sales, filling 1789 MediCabilis prescriptions in April.
" Prescient Therapeutics (ASX:PTX) signs new research agreement with Peter MacCallum Cancer Centre
Prescient Therapeutics (PTX) has announced a new research program with the Peter MacCallum Cancer Centre to advance its next-generation CAR-T programs.
" Regeneus (ASX:RGS) secures $4.5 M for osteoarthritis trials
Clinical-stage regenerative medicine company Regeneus (RGS) has secured up to $4.5 million in a three-stage placement of the company’s shares to New Lif…
" Nyrada (ASX:NYR) pockets $1M tax rebate for 2020 drug development work
Drug developer Nyrada (NYR) has retreated slightly on the ASX today despite pocketing a million-dollar tax rebate from the Federal Government.
" Medadvisor (ASX:MDR) nets cash for digital U.S. initiatives
Medication management software company Medadvisor (MDR) has secured $5.25 million via a placement and locked in an $11.7 million loan facility.